Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Argus Health
Healthtrust
Teva
Cerilliant
Harvard Business School
Mallinckrodt
Cipla
Medtronic

Generated: December 10, 2018

DrugPatentWatch Database Preview

Details for Patent: 9,493,582

« Back to Dashboard

Summary for Patent: 9,493,582
Title:Alkylated cyclodextrin compositions and processes for preparing and using the same
Abstract: The present invention related to low-chloride alkylated cyclodextrin compositions, along with processes for preparing and using the same. The processes of the present invention provide alkylated cyclodextrins with low levels of drug-degrading agents and chloride.
Inventor(s): Antle; Vincent D. (Olathe, KS), Lopes; Alvaro (Loures, PT), Monteiro; Daniel (Loures, PT)
Assignee: Cydex Pharmaceuticals, Inc. (San Diego, CA)
Application Number:14/381,568
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,493,582
Patent Claim Types:
see list of patent claims
Use; Composition; Process; Formulation;

Drugs Protected by US Patent 9,493,582

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Melinta BAXDELA delafloxacin meglumine POWDER;INTRAVENOUS 208611-001 Jun 19, 2017 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Onyx Therap KYPROLIS carfilzomib POWDER;INTRAVENOUS 202714-003 Jun 7, 2018 RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Onyx Therap KYPROLIS carfilzomib POWDER;INTRAVENOUS 202714-002 Jun 3, 2016 RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Onyx Therap KYPROLIS carfilzomib POWDER;INTRAVENOUS 202714-001 Jul 20, 2012 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Spectrum Pharms EVOMELA melphalan hydrochloride POWDER;IV (INFUSION) 207155-001 Mar 10, 2016 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Lundbeck Pharms Llc CARNEXIV carbamazepine SOLUTION;INTRAVENOUS 206030-001 Oct 7, 2016 DISCN Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Merck Sharp Dohme NOXAFIL posaconazole SOLUTION;INTRAVENOUS 205596-001 Mar 13, 2014 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Foreign Priority and PCT Information for Patent: 9,493,582

PCT Information
PCT FiledFebruary 27, 2013PCT Application Number:PCT/US2013/028094
PCT Publication Date:September 06, 2013PCT Publication Number: WO2013/130666

International Family Members for US Patent 9,493,582

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2013226073 ➤ Sign Up
Australia 2016210707 ➤ Sign Up
Canada 2865950 ➤ Sign Up
China 104704007 ➤ Sign Up
European Patent Office 2748205 ➤ Sign Up
Hong Kong 1211311 ➤ Sign Up
Japan 2015508846 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Deloitte
Daiichi Sankyo
Federal Trade Commission
Express Scripts
Chinese Patent Office
US Department of Justice
Accenture
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.